This product uses the truncated VZV gE protein with independent intellectual property rights of our company as the antigen, and contains major B-cell and T-cell epitopes. Equipped with the self-developed dual adjuvant system, it can induce the body to produce strong specific humoral and cellular immune responses. All adjuvants used have been applied in marketed vaccines.